Cargando…
Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USA
BACKGROUND: There is limited evidence on the clinical and cost benefits of screening for atrial fibrillation (AF) with electrocardiogram (ECG) in asymptomatic adults. METHODS: We adapted a previously published Markov model to evaluate the clinical and economic impact of one-time screening for non-va...
Autores principales: | Oguz, Mustafa, Lanitis, Tereza, Li, Xiaoyan, Wygant, Gail, Singer, Daniel E., Friend, Keith, Hlavacek, Patrick, Nikolaou, Andreas, Mattke, Soeren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347708/ https://www.ncbi.nlm.nih.gov/pubmed/31849021 http://dx.doi.org/10.1007/s40258-019-00542-y |
Ejemplares similares
-
Cost-effectiveness of atrial fibrillation screening in Canadian community practice
por: Andrade, Jason G., et al.
Publicado: (2022) -
Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021) -
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
por: Dhamane, Amol D, et al.
Publicado: (2021) -
Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure
por: Amin, Alpesh, et al.
Publicado: (2019) -
Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)